98. Eosinophilic gastrointestinal disease Clinical trials / Disease details
Clinical trials : 172 / Drugs : 149 - (DrugBank : 39) / Drug target genes : 38 - Drug target pathways : 135
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05606705 (ClinicalTrials.gov) | December 5, 2022 | 31/10/2022 | A Study of Baked Milk Tolerance to Treat Eosinophilic Esophagtis | A Pilot Trial of Baked Milk Introduction in Patients With Milk-triggered Eosinophilic Esophagitis | Eosinophilic Esophagitis | Dietary Supplement: Baked Milk | Mayo Clinic | NULL | Enrolling by invitation | 18 Years | 90 Years | All | 26 | N/A | United States |
| 2 | NCT02579876 (ClinicalTrials.gov) | October 2015 | 14/10/2015 | Milk Patch for Eosinophilic Esophagitis | A Double, Blind Placebo-controlled, Randomized Trial to Study Efficacy and Safety of the Viaskin Milk for Treating Milk Induced Eosinophilic Esophagitis in Children | Eosinophilic Esophagitis;Milk Allergy | Drug: Viaskin Milk 500 mcg;Drug: Viaskin Placebo | Children's Hospital of Philadelphia | DBV Technologies | Completed | 4 Years | 17 Years | All | 20 | Phase 2 | United States |